The critical influence of the intermediate category on interpretation errors in revised EUCAST and CLSI antimicrobial susceptibility testing guidelines

Clinical Microbiology and Infection

Volumn 19, Issue 2, 2013, Pages

  Hombach, M ^a   Bottger E C ^a   Roos, M ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

CLSI; Epidemiological cut off; EUCAST; Major errors; Very major errors

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; ERTAPENEM; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; NORFLOXACIN; TOBRAMYCIN;

ACCURACY; ACINETOBACTER BAUMANNII; ANALYTICAL ERROR; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; COAGULASE NEGATIVE STAPHYLOCOCCUS; DISK DIFFUSION; ENTEROBACTERIACEAE; ESCHERICHIA COLI; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROBABILITY; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; WILD TYPE;

EID: 84873523169     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12090     Document Type: Article

References (29)

1. Bauer AW, Roberts CE Jr, Kirby WM. Single disc versus multiple disc and plate dilution techniques for antibiotic sensitivity testing. Antibiot Annu 1959; 7: 574-580.
2. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. CLSI document M 100-S 22. Wayne, PA, USA: CLSI, 2012.
3. European Committee on Antimicrobial Susceptibility Testing. EUCAST Disk diffusion manual 2012. http://www.eucast.org/eucast_susceptibility_testing/disk_diffusion_methodology (21st August 2012, date last accessed).
4. Turnidge J, Paterson DL. Setting and revising antibacterial susceptibility breakpoints. Clin Microbiol Rev 2007; 20: 391-408.
5. European Committee on Antimicrobial Susceptibility Testing. EUCAST definitions http://www.srga.org/eucastwt/eucastdefinitions.htm (21st August 2012, date last accessed).
6. Brunden MN, Zurenko GE, Kapik B. Modification of the error-rate bounded classification scheme for use with two mic break points. Diagn Microbiol Infect Dis 1992; 15: 135-140.
7. Metzler CM, DeHaan RM. Susceptibility tests of anaerobic bacteria: statistical and clinical considerations. J Infect Dis 1974; 130: 588-594.
8. European Committee on Antimicrobial Susceptibility Testing. EUCAST rationale documents. http://www.eucast.org/documents/rd/ (21st August 2012, date last accessed).
9. European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 2.0. 2012. http://www.eucast.org/clinical_breakpoints (21st August 2012, date last accessed).
10. Andrews JM, Howe RA. BSAC standardized disc susceptibility testing method (version 10). J Antimicrob Chemother 2011; 66: 2726-2757.
11. Comité de l'Antibiogramme de la Societe Francaise de Microbiologie. Recommandations 2012. http://www.sfm-microbiologie.org/pages/?page=801&type=actualites&id=256 (21st August last accessed).
12. Altman DG. Practical statistics for medical research. Appendix B, Table B1, London, UK: Chapman & Hall/CRC Texts in Statistical Science, 1991; 515.
13. Altman DG, Newcombe RG. Proportions and their differences and diagnostic tests. In: Altman DG, Machin D, Bryant TN, Gardner JM, eds, Statistics with confidence, 2nd edn. London, U.K.: BMJ Books, 2000; 46-48, 106-107.
14. Clinical and Laboratory Standards Institute. Development of in vitro susceptibility testing criteria and quality control parameters; approved guideline, 3rd edn. CLSI document M23-A3. Wayne, PA: CLSI, 2008.
15. Craig BA. Modeling approach to diameter breakpoint determination. Diagn Microbiol Infect Dis 2000; 36: 193-202.
16. Kronvall G, Giske CG, Kahlmeter G. Setting interpretive breakpoints for antimicrobial susceptibility testing using disk diffusion. Int J Antimicrob Agents 2011; 38: 281-290.
17. Kronvall G, Kahlmeter G, Myhre E, Galas MF. A new method for normalized interpretation of antimicrobial resistance from disk test results for comparative purposes. Clin Microbiol Infect 2003; 9: 120-132.
18. European Committee on Antimicrobial Susceptibility Testing. Setting breakpoints for new agents, EUCAST SOP 1.0, 2010. http://www.eucast.org/documents/sops/ (21st August 2012, date last accessed).
19. Bjorklind A, Ringertz S, Kronvall G. Types of interpretive errors in susceptibility testing. Zone breakpoints for norfloxacin disk diffusion testing. APMIS 1989; 97: 941-948.
20. Winstanley T, Courvalin P. Expert systems in clinical microbiology. Clin Microbiol Rev 2011; 24: 515-556.
21. Livermore DM, Andrews JM, Hawkey PM et al. Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly? J Antimicrob Chemother 2012; 67: 1569-1577.
22. Kronvall G, Holst E. Calibration of the disk diffusion test for trovafloxacin susceptibility testing of four anaerobic species. Clin Microbiol Infect 2000; 6: 195-201.
23. Kronvall G, Rylander M, Walder M et al. Calibration of disk diffusion antibiotic susceptibility testing: species-related trovafloxacin interpretive zone breakpoints and selection of disk potency. Scand J Infect Dis 1999; 31: 573-578.
24. Mouton RP, van Klingeren B. Standardization of antibiotic sensitivity tests. Scand J Infect Dis 1982; 14: 243-244.
25. European Committee on Antimicrobial Susceptibility Testing. Zone diameter distributions. http://www.eucast.org/zone_diameter_distributions/ (21st August 2012, date last accessed).
26. Kronvall G. Analysis of a single reference strain for determination of gentamicin regression line constants and inhibition zone diameter breakpoints in quality control of disk diffusion antibiotic susceptibility testing. J Clin Microbiol 1982; 16: 784-793.
27. Kronvall G, Ringertz S, Karlsson I, Goransson E, Dornbusch K. Laboratory- and species-specific interpretive breakpoints for disk diffusion tests of chloramphenicol susceptibility of Haemophilus influenzae. Antimicrob Agents Chemother 1988; 32: 1484-1489.
28. O'Brien TF, Norton RA, Kent RL, Medeiros AA. International surveillance of prevalence of antibiotic resistance. J Antimicrob Chemother 1977; 3 (suppl C): 59-66.
29. Olsson-Liljequist B, Koljalg S, Karlsson I, Kronvall G. Calibration of fusidic acid disk diffusion susceptibility testing of Staphylococcus aureus. APMIS 2002; 110: 690-696.